Life sciences, health
The life sciences and healthcare sector is constantly evolving, driven by technological and scientific advancements that are transforming medical practices and related industries. Legal challenges in this sector are complex and diverse. We work with pharmaceutical companies, biotechnology firms, medical device manufacturers, research institutes, academics, hospitals, private healthcare providers, the cosmetics and chemical industries, investment funds, service companies, and intermediaries, including competitiveness clusters.
Our law firm offers a wide range of cross-disciplinary skills, forming project-based teams to support the entire lifecycle of products or services. We provide both advisory and litigation services, focusing on regulatory, contractual, tax, corporate, intellectual property, public law, and competition law matters, including state aid issues.
Areas of Practice
ADR & Mediation
We prioritize alternative dispute resolution (ADR) and mediation to resolve conflicts related to collaborative research, distribution, or franchising within the medical sector.
Litigation
We defend our clients in complex disputes involving intellectual property rights, such as patents and trademarks, as well as regulatory litigation concerning the market approval of medical devices and innovative biotech products.
Taxation
Our tax experts address issues related to restructuring, mergers and acquisitions, and research tax credits, ensuring tax optimization tailored to the specific needs of businesses in the sector.
Corporate Law
We assist clients in structuring, financing, and governance projects, whether for biotech startups or established pharmaceutical companies.
Intellectual Property Law
Protecting and maximizing the value of intellectual property is central to our services. We specialize in patents, trademarks, consortium agreements, data management, and GDPR compliance.
Public Law
We handle regulatory matters concerning medical devices, pharmaceutical approvals, and CE marking requirements.
International Arbitration
We support companies and institutions in international arbitration cases involving complex disputes related to consortium agreements, distribution contracts, and patent violations in the life sciences sector.
Domestic Arbitration
We manage national litigation involving disputes over research contracts, regulatory disputes concerning CE marking, or contractual disputes between industrial partners.
Competition Law
Our lawyers ensure the compliance of companies’ commercial practices in the medical and pharmaceutical sectors, particularly for distribution or franchise agreements.
Regulatory Law
We assist clients in meeting regulatory requirements, including market authorizations (AMM), compliance audits for medical devices, and oversight by regulatory authorities.
Financing
Our teams advise on funding dedicated to research and development, acquisitions in the life sciences sector, or fundraising for innovative biotech projects.
Mergers and Acquisitions (M&A)
We support companies in strategic mergers and acquisitions, whether for pharmaceutical firms, medical device manufacturers, or biotech startups.
Restructuring
We provide legal solutions for optimizing corporate reorganizations as part of strategic transformations or regulatory compliance.
Corporate Law
Our corporate law experts support sector players in creation and management of adapted structures, whether start-ups, joint ventures, or established companies.
Examples of Support
Awards
De Gaulle Fleurance & Associés advises both domestic and international healthcare and pharmaceutical clients, often assisting with regulatory advice. The team acts on the implementation of procurement regulation and data privacy. The law firm also offers assistance with corporate matters, including the negotiation of contracts and collaboration agreements.
De Gaulle Fleurance & Associés houses a broad team which handles the full range of issues concerning competition law, IT, and data protection within life sciences. The team regularly appears before the French administrative courts and the French Competition Authority in disputes concerning marketing authorisations and allegations of abuse of dominant position.
They are especially good in dealing with complex matters at the cross-roads between digital and life sciences. They are used to working on cutting-edge topics.